Feature | Implantable Cardioverter Defibrillator (ICD) | July 02, 2015

Boston Scientific Initiates Global Study of Emblem Subcutaneous Implantable Defibrillator

Study examines primary prevention in patients with low ejection fraction

Boston Scientific, Emblem, S-ICD, UNTOUCHED study, TV-ICDs, MADIT-RIT study

July 2, 2015 - Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the Emblem subcutaneous implantable defibrillator (S-ICD). The device is indicated for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function (left ventricular ejection fraction </= 35 percent).

Primary prevention patients do not have a previously documented life-threatening arrhythmic event, but are at risk of sudden cardiac death and thereby indicated to receive an implantable defibrillator. This group of patients represents the highest proportion of patients that are implanted with transvenous ICD (TV-ICDs) devices today in the United States and European Union. 

In order to further demonstrate the usefulness of the S-ICD System in this particular patient population, the UNTOUCHED study will compare outcomes during an 18-month follow-up period to objective performance criteria derived from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) study. The landmark MADIT-RIT study evaluated shock rates in 1,500 patients implanted with TV-ICD devices and is one of the largest randomized trials to assess shock reduction strategies for TV-ICD devices.

"The MADIT-RIT trial demonstrated that standardized programming using higher rate cutoffs and longer delays to therapy reduces the incidence of inappropriate shocks for TV-ICDs," said Lucas Boersma, M.D., EU principal investigator and electrophysiologist at St. Antonius Hospital, The Netherlands. "The UNTOUCHED trial will examine the incidence of all-cause shocks when using the EMBLEM S-ICD System with standardized therapy settings similar to MADIT-RIT."

The first patient enrolled in the global, multi-site, prospective, non-randomized UNTOUCHED study received an Emblem implant by Craig Barr, M.D., cardiologist at Russells Hall Hospital in Dudley, England. The study will enroll a minimum of 2,015 patients at up to 200 sites worldwide. Enrollments in the United States will begin later this summer.

"In the published data to date, we have observed S-ICD devices demonstrate comparable inappropriate shock rates for arrhythmias to TV-ICDs," said Michael Gold, M.D., Ph.D., U.S. principal investigator and chief of cardiology and the Michael E. Assey professor of medicine at Medical University of South Carolina, Charleston. "Ideally, this trial will demonstrate S-ICD devices can either meet or improve upon the inappropriate shock rates experiences with TV-ICDs in MADIT-RIT within this large patient population."

The Emblem S-ICD system received CE mark earlier this year and was approved by the U.S. Food & Drug Administration (FDA) in March of 2015. The device launched in Europe starting in May, and became commercially available in the United States in June, in preparation for a planned full U.S. launch during the third quarter of 2015.

For more information: www.bostonscientific.com

Related Content

Videos | Sudden Cardiac Arrest | July 05, 2018
Malissa Wood, M.D., co-director of the Corrigan Women’s Heart Health Program, Massachusetts General Hospital, explain
Sudden cardiac arrest - Exposure to Air Pollution on Cold Days Can Trigger Sudden Cardiac Death in Women. #HRS2018
News | Sudden Cardiac Arrest | May 16, 2018
May 16, 2018 — A new study shows that women exposed to particular matter (PM) and lower temperatures for even a short
Videos | Sudden Cardiac Arrest | March 14, 2018
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those bein
Feature | Sudden Cardiac Arrest | January 31, 2018
January 31, 2018 — Overall survival has improved for the about 200,000 patients experiencing in-hospital cardiac arre
MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest | October 18, 2017
Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-...
Health Insurance Expansion Linked to Fewer Sudden Cardiac Arrests
News | Sudden Cardiac Arrest | July 11, 2017
The incidence of sudden cardiac arrest, an often deadly loss of heart function, declined significantly among previously...
Cedars-Sinai Team Develops New Sudden Cardiac Arrest Risk Assessment Score
News | Sudden Cardiac Arrest | June 26, 2017
A Cedars-Sinai Heart Institute investigator and his team have developed a new risk assessment tool that brings...
wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest | May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
Videos | Sudden Cardiac Arrest | October 28, 2016
This video, provided by Zoll, demonstrates how cardiologists can explain sudden cardiac death to patients.
LifePak, AED, sudden cardiac arrest, defibrillator, automatic external defibrillator

A Physio-Control LifePak CR Plus defibrillator shown in use during a hand-off to paramedics, who use larger, more sophisticated defibrillator-monitors (behind gloved paramedic).

Feature | Sudden Cardiac Arrest | September 28, 2016 | Allied Market Research
Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock throug
Overlay Init